Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 14

Results For "IDA"

1783 News Found

Merck announces Phase 3 trial initiations for 4 Investigational Candidates from hematology and oncology pipeline
Diagnostic Center | January 06, 2024

Merck announces Phase 3 trial initiations for 4 Investigational Candidates from hematology and oncology pipeline

Comprehensive clinical development programs being initiated for each investigational candidate


Wockhardt Q2 FY24 consolidated loss lowers at Rs. 77 Cr
News | November 15, 2023

Wockhardt Q2 FY24 consolidated loss lowers at Rs. 77 Cr

Wockhardt has reported total income of Rs. 777 crores during the period ended September 30, 2023


Natco Pharma posts consolidated Q2F Y24 PAT of Rs. 369 Cr
News | November 15, 2023

Natco Pharma posts consolidated Q2F Y24 PAT of Rs. 369 Cr

Natco Pharma has reported total income of Rs. 1060.8 crores during the period ended September 30, 2023


Solara Active Pharma Sciences posts consolidated Q2 FY2024 loss at Rs. 17.16 Cr
News | November 15, 2023

Solara Active Pharma Sciences posts consolidated Q2 FY2024 loss at Rs. 17.16 Cr

Solara Active Pharma Sciences has reported total income of Rs. 426.42 crores during the period ended September 30, 2023


Marksans Pharma posts Q2 FY24 consolidated PAT at Rs. 82.7 Cr
News | November 13, 2023

Marksans Pharma posts Q2 FY24 consolidated PAT at Rs. 82.7 Cr

US business grew by +12.8% YoY


Gland Pharma posts Q2 FY24 consolidated PAT at Rs. 194.08 Cr
News | November 07, 2023

Gland Pharma posts Q2 FY24 consolidated PAT at Rs. 194.08 Cr

Gland Pharma has reported total income of Rs. 1426.57 crores during the period ended September 30, 2023


Max Healthcare Institute reports Q2 FY24 consolidated PAT at Rs. 276.68 Cr
News | November 07, 2023

Max Healthcare Institute reports Q2 FY24 consolidated PAT at Rs. 276.68 Cr

Max Healthcare Institute has reported total income of Rs. 1408.64 crores during the period ended September 30, 2023


Divis Laboratories posts Q2 FY24 consolidated PAT at Rs. 348 Cr
News | November 07, 2023

Divis Laboratories posts Q2 FY24 consolidated PAT at Rs. 348 Cr

Divi's Laboratories Limited has reported total income of Rs. 1995 crores during the period ended September 30, 2023


Zydus Wellness consolidated Q2 FY24 PAT drops to Rs. 5.9 Cr
News | November 07, 2023

Zydus Wellness consolidated Q2 FY24 PAT drops to Rs. 5.9 Cr

Zydus Wellness has reported total income of Rs. 444 crores during the period ended September 30, 2023


Metropolis Healthcare reports Q2 FY24 consolidated PAT at Rs. 35.45 Cr
News | November 06, 2023

Metropolis Healthcare reports Q2 FY24 consolidated PAT at Rs. 35.45 Cr

Metropolis Healthcare has reported total income of Rs. 309.71 crores during the period ended September 30, 2023